We are looking for Biotech Investment Analyst — Drug Asset & Company Assessment candidates for a project delivered through the hiring partner.
What you'll do
- Create and critique rubrics that analyze commercial drugs and drug-development programs
- Provide overall company and asset assessment — mechanism, clinical data, competitive position, and value drivers
- Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions
- Apply your assessment across the pilot's set of companies (~5–10)
What you need
- US-based biotech / healthcare investment analyst with a specialist-fund background
- Familiarity with biotech/pharma development programs
- Able to assess a drug asset and the company behind it end-to-end
- 5+ years evaluating biotech/pharma companies or assets
Who you work with
Project and contracting process: the hiring partner. Applications continue on the provider's website.
Pay and hours
This role pays $120–$200/hr, for 15 h/week. The work is remote. That is about 88% above the $85 an hour median for science & research roles open now.
Who can apply from where
Open to candidates in United States. With a profile, Tier1 checks your country and languages against this role and every other before you apply.